26 of 63 diabetes mellitus patients (41.3%) received treatment prior to the stroke,with 5 of 26 treatment patients (19.2%) received insulin therapy and the remaining 21 of 26 patients (80.8%) received oral hypoglycemic agent treatment. The gene discussed is INS; the disease is diabetes mellitus.